Home > Our Partners > Parse Biosciences
Parse Biosciences is a Seattle-based company with the mission of accelerating progress in human health and scientific research.
They are providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Single cell RNA sequencing has already enabled breakthroughs in developmental biology, stem cell therapy, immunotherapy, and cancer treatments. Our foundational Evercode™ combinatorial barcoding technology is driving the next generation of discoveries.
Combinatorial barcoding enables you to dramatically scale up the cells and samples per experiment.
If you have a centrifuge, thermal cycler, and some pipettes, you’re
ready to go.
Better detect lowly expressed genes and avoid ambient RNA common in droplet-based single cell sequencing.
Fix and store samples as they come in for up to 6 months and then run together later on your schedule.
Unleash the power of combinatorial barcoding with Evercode™. Our innovative technology revolutionizes the labeling process by assigning cell-specific barcode combinations to molecules, setting the stage for groundbreaking research.
Here’s how it works:
Discover the full potential of your lab with Evercode™. Revolutionize your research and unlock new possibilities with our cutting-edge combinatorial barcoding technology.
Experience unparalleled sensitivity at any scale with Evercode™ combinatorial barcoding technology. Here’s why it’s the superior choice for your research:
Elevate your research to new heights with Evercode™ combinatorial barcoding technology. Uncover hidden insights, accelerate discoveries, and push the boundaries of scientific exploration with unmatched sensitivity and precision.
Get a call from your local Decode Science representative to help you find the best fit genomics products for you.
Or give us a call at:
Simply add your details below and get quick access to the brochure.
Simply add your details below and get quick access to the brochure.
Simply add your details below and get quick access to the brochure.